Reimbursement Scheme Paxneury® (guanfacine)
The health insurer does not fully reimburse Paxneury® 1 mg, 2 mg, 3 mg, 4 mg tablets. The producer of this medicine has therefore...
TBR Nederland Instructional videos now available
TBR Nederland now has instructional videos available to help patients create an account and submit a claim. The following...
Termination Reimbursement scheme Broxil®
From August 1, 2025 Broxil® 125 mg / 5 mL, powder for oral suspension is fully reimbursed by the health insurance. For this reason...
Termination Reimbursement scheme Forxiga®/Xigduo® - Diabetes
As from the 1st of August 2025 the “bijlage 2 voorwaarden” for Forxiga® and Xigduo® have been withdrawn. This means that per 1st...
Termination Reimbursement scheme Cresemba® 40 mg en 100mg
From August 1st 2025 onwards, Cresemba® 40 mg en 100mg is fully reimbursed by the health insurer. Therefore the...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine